Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma-Reference-Cited by-同舟云学术

Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma

Published:2011-02-16 Issue:2 Volume:14 Page:161-165
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Okita Natsuko Tsuda,Kato Ken,Takahari Daisuke,Hirashima Yoshinori,Nakajima Takako E.,Matsubara Junichi,Hamaguchi Tetsuya,Yamada Yasuhide,Shimada Yasuhiro,Taniguchi Hirokazu,Shirao Kuniaki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-011-0025-5.pdf

Reference19 articles.

1. Godwin JD. Carcinoid tumors. Cancer. 1975;36:560–9.

2. Solcia E, Kloeppel G, Sobin LH. World Health Organization: International histological classification of tumours: histological typing of endocrine tumours. Berlin: Springer; 2000.

3. Botch K, Ahren B, Ahlman H, Falkmer S, Granerus G, Grimelius L. Gastric carcinoids. Biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005;242:64–73.

4. Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730–9.

5. Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer. 1991;68:227–32.

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal management of foregut neuroendocrine neoplasms;Best Practice & Research Clinical Gastroenterology;2024-02

2. Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis;Cancer Medicine;2024-02

3. Endoscopic features of gastric neuroendocrine carcinoma;Journal of Gastroenterology and Hepatology;2023-08

4. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma;Cancer and Metastasis Reviews;2023-07-08

5. Late-stage esophageal neuroendocrine carcinoma in a patient treated with tislelizumab combined with anlotinib: a case report;Journal of International Medical Research;2023-07